 | • レポートコード：MRC2-11QY12033 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はゲノミクスバイオマーカーのグローバル市場について調査・分析したレポートです。種類別（腫瘍、循環器疾患、神経疾患）市場規模、用途別（診断・研究所、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ゲノミクスバイオマーカーの競争状況、市場シェア ・世界のゲノミクスバイオマーカー市場：種類別市場規模 2015年-2020年（腫瘍、循環器疾患、神経疾患） ・世界のゲノミクスバイオマーカー市場：種類別市場規模予測 2021年-2026年（腫瘍、循環器疾患、神経疾患） ・世界のゲノミクスバイオマーカー市場：用途別市場規模 2015年-2020年（診断・研究所、病院） ・世界のゲノミクスバイオマーカー市場：用途別市場規模予測 2021年-2026年（診断・研究所、病院） ・北米のゲノミクスバイオマーカー市場分析：米国、カナダ ・ヨーロッパのゲノミクスバイオマーカー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのゲノミクスバイオマーカー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のゲノミクスバイオマーカー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのゲノミクスバイオマーカー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche Diagnostics、Myriad Genetics、QIAGEN、Thermo Fisher Scientific、Bio-Rad Laboratories ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).
The increasing instances of low-cost clinical trials in developing countries will drive the growth prospects for the global genomics biomarkers market until the end of 2021. This globalization of clinical trials has been credited to numerous components that include organized trials, the willingness of members facilitating the enrollment, accessibility of qualified local investigators, enhanced opportunities in various Tier 2 and Tier 3 countries, and lower expenses of clinical trials in developing nations. Some of the other factors responsible for the increasing preference for disease-based genomic biomarkers such as cancer biomarkers testing includes the faster and precise analysis of diseases and potential lowering in volume and time involved in clinical trials.
Market Analysis and Insights: Global Genomics Biomarkers Market
The global Genomics Biomarkers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Genomics Biomarkers Scope and Market Size
Genomics Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genomics Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche Diagnostics
Myriad Genetics
QIAGEN
Thermo Fisher Scientific
Bio-Rad Laboratories
…
Market segment by Type, the product can be split into
Oncology
Cardiovascular Diseases
Neurological Diseases
Market segment by Application, split into
Diagnostic and Research Laboratories
Hospitals
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Genomics Biomarkers Revenue
1.4 Market by Type
1.4.1 Global Genomics Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oncology
1.4.3 Cardiovascular Diseases
1.4.4 Neurological Diseases
1.5 Market by Application
1.5.1 Global Genomics Biomarkers Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic and Research Laboratories
1.5.3 Hospitals
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Genomics Biomarkers Market Perspective (2015-2026)
2.2 Global Genomics Biomarkers Growth Trends by Regions
2.2.1 Genomics Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Genomics Biomarkers Historic Market Share by Regions (2015-2020)
2.2.3 Genomics Biomarkers Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Genomics Biomarkers Market Growth Strategy
2.3.6 Primary Interviews with Key Genomics Biomarkers Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Genomics Biomarkers Players by Market Size
3.1.1 Global Top Genomics Biomarkers Players by Revenue (2015-2020)
3.1.2 Global Genomics Biomarkers Revenue Market Share by Players (2015-2020)
3.1.3 Global Genomics Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Genomics Biomarkers Market Concentration Ratio
3.2.1 Global Genomics Biomarkers Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Genomics Biomarkers Revenue in 2019
3.3 Genomics Biomarkers Key Players Head office and Area Served
3.4 Key Players Genomics Biomarkers Product Solution and Service
3.5 Date of Enter into Genomics Biomarkers Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Genomics Biomarkers Historic Market Size by Type (2015-2020)
4.2 Global Genomics Biomarkers Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Genomics Biomarkers Market Size by Application (2015-2020)
5.2 Global Genomics Biomarkers Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Genomics Biomarkers Market Size (2015-2020)
6.2 Genomics Biomarkers Key Players in North America (2019-2020)
6.3 North America Genomics Biomarkers Market Size by Type (2015-2020)
6.4 North America Genomics Biomarkers Market Size by Application (2015-2020)
7 Europe
7.1 Europe Genomics Biomarkers Market Size (2015-2020)
7.2 Genomics Biomarkers Key Players in Europe (2019-2020)
7.3 Europe Genomics Biomarkers Market Size by Type (2015-2020)
7.4 Europe Genomics Biomarkers Market Size by Application (2015-2020)
8 China
8.1 China Genomics Biomarkers Market Size (2015-2020)
8.2 Genomics Biomarkers Key Players in China (2019-2020)
8.3 China Genomics Biomarkers Market Size by Type (2015-2020)
8.4 China Genomics Biomarkers Market Size by Application (2015-2020)
9 Japan
9.1 Japan Genomics Biomarkers Market Size (2015-2020)
9.2 Genomics Biomarkers Key Players in Japan (2019-2020)
9.3 Japan Genomics Biomarkers Market Size by Type (2015-2020)
9.4 Japan Genomics Biomarkers Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Genomics Biomarkers Market Size (2015-2020)
10.2 Genomics Biomarkers Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Genomics Biomarkers Market Size by Type (2015-2020)
10.4 Southeast Asia Genomics Biomarkers Market Size by Application (2015-2020)
11 India
11.1 India Genomics Biomarkers Market Size (2015-2020)
11.2 Genomics Biomarkers Key Players in India (2019-2020)
11.3 India Genomics Biomarkers Market Size by Type (2015-2020)
11.4 India Genomics Biomarkers Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Genomics Biomarkers Market Size (2015-2020)
12.2 Genomics Biomarkers Key Players in Central & South America (2019-2020)
12.3 Central & South America Genomics Biomarkers Market Size by Type (2015-2020)
12.4 Central & South America Genomics Biomarkers Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Details
13.1.2 Roche Diagnostics Business Overview
13.1.3 Roche Diagnostics Genomics Biomarkers Introduction
13.1.4 Roche Diagnostics Revenue in Genomics Biomarkers Business (2015-2020))
13.1.5 Roche Diagnostics Recent Development
13.2 Myriad Genetics
13.2.1 Myriad Genetics Company Details
13.2.2 Myriad Genetics Business Overview
13.2.3 Myriad Genetics Genomics Biomarkers Introduction
13.2.4 Myriad Genetics Revenue in Genomics Biomarkers Business (2015-2020)
13.2.5 Myriad Genetics Recent Development
13.3 QIAGEN
13.3.1 QIAGEN Company Details
13.3.2 QIAGEN Business Overview
13.3.3 QIAGEN Genomics Biomarkers Introduction
13.3.4 QIAGEN Revenue in Genomics Biomarkers Business (2015-2020)
13.3.5 QIAGEN Recent Development
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Details
13.4.2 Thermo Fisher Scientific Business Overview
13.4.3 Thermo Fisher Scientific Genomics Biomarkers Introduction
13.4.4 Thermo Fisher Scientific Revenue in Genomics Biomarkers Business (2015-2020)
13.4.5 Thermo Fisher Scientific Recent Development
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Details
13.5.2 Bio-Rad Laboratories Business Overview
13.5.3 Bio-Rad Laboratories Genomics Biomarkers Introduction
13.5.4 Bio-Rad Laboratories Revenue in Genomics Biomarkers Business (2015-2020)
13.5.5 Bio-Rad Laboratories Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Genomics Biomarkers Key Market Segments
Table 2. Key Players Covered: Ranking by Genomics Biomarkers Revenue
Table 3. Ranking of Global Top Genomics Biomarkers Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Genomics Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oncology
Table 6. Key Players of Cardiovascular Diseases
Table 7. Key Players of Neurological Diseases
Table 8. Global Genomics Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Genomics Biomarkers Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Genomics Biomarkers Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Genomics Biomarkers Market Share by Regions (2015-2020)
Table 12. Global Genomics Biomarkers Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Genomics Biomarkers Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Genomics Biomarkers Market Growth Strategy
Table 18. Main Points Interviewed from Key Genomics Biomarkers Players
Table 19. Global Genomics Biomarkers Revenue by Players (2015-2020) (Million US$)
Table 20. Global Genomics Biomarkers Market Share by Players (2015-2020)
Table 21. Global Top Genomics Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics Biomarkers as of 2019)
Table 22. Global Genomics Biomarkers by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Genomics Biomarkers Product Solution and Service
Table 25. Date of Enter into Genomics Biomarkers Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Genomics Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 28. Global Genomics Biomarkers Market Size Share by Type (2015-2020)
Table 29. Global Genomics Biomarkers Revenue Market Share by Type (2021-2026)
Table 30. Global Genomics Biomarkers Market Size Share by Application (2015-2020)
Table 31. Global Genomics Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 32. Global Genomics Biomarkers Market Size Share by Application (2021-2026)
Table 33. North America Key Players Genomics Biomarkers Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Genomics Biomarkers Market Share (2019-2020)
Table 35. North America Genomics Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 36. North America Genomics Biomarkers Market Share by Type (2015-2020)
Table 37. North America Genomics Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 38. North America Genomics Biomarkers Market Share by Application (2015-2020)
Table 39. Europe Key Players Genomics Biomarkers Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Genomics Biomarkers Market Share (2019-2020)
Table 41. Europe Genomics Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Genomics Biomarkers Market Share by Type (2015-2020)
Table 43. Europe Genomics Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Genomics Biomarkers Market Share by Application (2015-2020)
Table 45. China Key Players Genomics Biomarkers Revenue (2019-2020) (Million US$)
Table 46. China Key Players Genomics Biomarkers Market Share (2019-2020)
Table 47. China Genomics Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 48. China Genomics Biomarkers Market Share by Type (2015-2020)
Table 49. China Genomics Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 50. China Genomics Biomarkers Market Share by Application (2015-2020)
Table 51. Japan Key Players Genomics Biomarkers Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Genomics Biomarkers Market Share (2019-2020)
Table 53. Japan Genomics Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Genomics Biomarkers Market Share by Type (2015-2020)
Table 55. Japan Genomics Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Genomics Biomarkers Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Genomics Biomarkers Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Genomics Biomarkers Market Share (2019-2020)
Table 59. Southeast Asia Genomics Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Genomics Biomarkers Market Share by Type (2015-2020)
Table 61. Southeast Asia Genomics Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Genomics Biomarkers Market Share by Application (2015-2020)
Table 63. India Key Players Genomics Biomarkers Revenue (2019-2020) (Million US$)
Table 64. India Key Players Genomics Biomarkers Market Share (2019-2020)
Table 65. India Genomics Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 66. India Genomics Biomarkers Market Share by Type (2015-2020)
Table 67. India Genomics Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 68. India Genomics Biomarkers Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Genomics Biomarkers Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Genomics Biomarkers Market Share (2019-2020)
Table 71. Central & South America Genomics Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Genomics Biomarkers Market Share by Type (2015-2020)
Table 73. Central & South America Genomics Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Genomics Biomarkers Market Share by Application (2015-2020)
Table 75. Roche Diagnostics Company Details
Table 76. Roche Diagnostics Business Overview
Table 77. Roche Diagnostics Product
Table 78. Roche Diagnostics Revenue in Genomics Biomarkers Business (2015-2020) (Million US$)
Table 79. Roche Diagnostics Recent Development
Table 80. Myriad Genetics Company Details
Table 81. Myriad Genetics Business Overview
Table 82. Myriad Genetics Product
Table 83. Myriad Genetics Revenue in Genomics Biomarkers Business (2015-2020) (Million US$)
Table 84. Myriad Genetics Recent Development
Table 85. QIAGEN Company Details
Table 86. QIAGEN Business Overview
Table 87. QIAGEN Product
Table 88. QIAGEN Revenue in Genomics Biomarkers Business (2015-2020) (Million US$)
Table 89. QIAGEN Recent Development
Table 90. Thermo Fisher Scientific Company Details
Table 91. Thermo Fisher Scientific Business Overview
Table 92. Thermo Fisher Scientific Product
Table 93. Thermo Fisher Scientific Revenue in Genomics Biomarkers Business (2015-2020) (Million US$)
Table 94. Thermo Fisher Scientific Recent Development
Table 95. Bio-Rad Laboratories Company Details
Table 96. Bio-Rad Laboratories Business Overview
Table 97. Bio-Rad Laboratories Product
Table 98. Bio-Rad Laboratories Revenue in Genomics Biomarkers Business (2015-2020) (Million US$)
Table 99. Bio-Rad Laboratories Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomics Biomarkers Market Share by Type: 2020 VS 2026
Figure 2. Oncology Features
Figure 3. Cardiovascular Diseases Features
Figure 4. Neurological Diseases Features
Figure 5. Global Genomics Biomarkers Market Share by Application: 2020 VS 2026
Figure 6. Diagnostic and Research Laboratories Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Genomics Biomarkers Report Years Considered
Figure 9. Global Genomics Biomarkers Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Genomics Biomarkers Market Share by Regions: 2020 VS 2026
Figure 11. Global Genomics Biomarkers Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Genomics Biomarkers Market Share by Players in 2019
Figure 14. Global Top Genomics Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics Biomarkers as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Genomics Biomarkers Revenue in 2019
Figure 16. North America Genomics Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Genomics Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Genomics Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Genomics Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Genomics Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Genomics Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Genomics Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
予測バイオマーカーの世界市場（～2026年） Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic. The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. Mar…- 心臓バイオマーカーの世界市場（～2026年） Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These …
- EPOバイオマーカーの世界市場（～2026年） Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers are used to increase the growth of red blood cells in the body by stimulating the bone marrow. Major factors contributing to the growth of the global EPO biomarkers market include increasing sede…
- がん分子バイオマーカーの世界市場（～2026年） Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluid…
- ゲノミクスの世界市場（～2026年） Genomics is the science of studying genomes and their interaction with a variety of stimuli. The global genomics market is chiefly driven by the intensifying level of competition in the global pharmaceutical industry and the increased use of genomics in research and development of new drug classes. …